All News

Navigating discussions around treatments for early-stage breast cancer may be difficult, but feeling comfortable with one’s cancer team and knowing about all the available options may help.

A man reflects on slight symptoms he was not concerned about leading up to his prostate cancer diagnosis.

Twenty years after 9/11, a retired firefighter reflects on the weeks following the attacks, as well as his own diagnosis of lung cancer six years later, in a newly published book.

Looking deeper into mortality rates highlights the importance of eliminating disparities in lung cancer and expanding screening eligibility for at-risk populations.

"Having been newly diagnosed myself, I saw how amazingly well she was doing and had been a survivor for about three years already," a lung cancer survivor writes about a connection she made with another survivor.

A woman describes the grueling experience of watching cancer attack her sister's body and wishing she could stop it.

One patient details how her oncology nurse was the caring energy she needed when undergoing treatment for cancer.

The first patient with bladder cancer was dosed in a phase 1/2 trial examining responses to an investigational immunotherapy.

A pancreatic cancer survivor makes a comparison between alcoholism and being a cancer survivor.

A patient with lung cancer explains how Terri Conneran, a patient advocate, helped her understand her disease and fight for proper care in a country with less options.

A lung cancer survivor shares a heartfelt tribute to Dr. Abraham Chachoua, who changed his life.

Two new FDA approvals for patients with lung cancer and EGFR exon 20 insertion mutations have given the subset its first targeted therapies.

A woman who has been living with metastatic breast cancer for seven years reflects on the strangeness of her body aging. “It’s the one thing I never imagined would happen after being diagnosed with and while living with a terminal illness – I’m actually getting old,” she writes.

From the death of Frederik Willem de Klerk to study results showing palm oil contains an acid that may cause cancer spread, here’s what’s happening in the cancer landscape this week.

Out of the darkness there is sometimes light, and in South Florida, Dr. Mark Block is a beacon of hope and light for many patients who’ve recently received a diagnosis of cancer.

The first patient has been enrolled in the APOLLO 613 Phase 1/2 clinical trial for CPI-613.

This study is the first to evaluate this rising trend of pancreatic cancer incidence in women under the age of 55.

As cancer survivorship rates increase, so does a survivor’s risk for chronic conditions that may impact their quality of life.

A cancer survivor describes how she faces her fears throughout health emergencies.

On this episode of the “Cancer Horizons” podcast, a young mother living with lung cancer shares the story of her cancer diagnosis and describes the once-in-a-lifetime coincidence of learning her neighbor has the same cancer type and mutation.

In an era of trauma, people whose buoyancy elevates both purpose and agency shine like a flashlight in the darkness. During the past year of uncertainty, Dave Bjork was that light for many.

One cancer survivor's garden helped her to cope and stay active during diagnosis, through treatment and into remission.

Studies show that quitting smoking after a lung cancer diagnosis has a huge payoff for patients. Many smoking cessation programs in cancer centers have tools to help patients quit.

A mother explains how difficult it is to forget about the painful memories of her daughter's cancer experience and how she is moving forward, one step at a time.

Even though recording conversations during a doctor’s appointment may make it easier for patients with cancer to retain information, some oncologists are uncomfortable with being recorded.

From microbiome-based therapies to reinventing an old drug and more, an expert from City of Hope explains the interest around emerging treatment options and approaches in metastatic kidney cancer.

A phase 1 trial of ONO-4685 was initiated for the evaluation of the antibody in patients with relapsed or refractory t-cell lymphoma.

Due to less travel and other treatment-related expenses, some patients with cancer prefer a telemedicine doctor’s visit over going into an office or clinic.